Founder, CEO and Chairman of the Board – Dr. Daniel Zurr
Dr. Daniel Zurr Ph.D., served as the CEO, Founder and Chairman of Quark Pharmaceuticals Inc. from
1993 to 2020, and the former CEO of Plantex Ikapharm (currently part of the Teva Group). Dr. Zurr has
vast experience in senior research and business management in the chemical and pharmaceutical
industries. Educated at Hebrew University of Jerusalem and PhD at Imperial College, London, UK.
Dr. Daniel Zurr Ph.D., served as the CEO, Founder and Chairman of Quark Pharmaceuticals Inc. from 1993 to 2020, and the former CEO of Plantex Ikapharm (currently part of the Teva Group). company. Dr. Zurr has vast experience in senior research and business management in the chemical and pharmaceutical industries.

The team – currently consists of scientists and drug development specialists with vast long-term experience in siRNA and gene editing technology.

Scientific Advisory Board – lead by Prof. Roger Kornberg
Prof. Kornberg is professor of structural biology at Stanford University School of Medicine Nobel Prize laureate in Chemistry in 2006 for his studies of the process by which genetic information from DNA is copied to RNA, “the molecular basis of eukaryotic transcription.